dapagliflozin
astrazeneca
[]
#dapaglifozin never stops to impress us! could chronic coronary syndrome be a target for this drug?
#esccongress 2022 
Interventional Cardiologist | Reseacher @HumanitasMilano, @fondazioneCLI #ValvularHeartDisease #MultimodalityImaging #Innovation Tweets my own